Surface-modified gold nanorods for specific cell targeting

• Published in: Journal of the Korean Physical Society Vol. 60; no. 10; pp. 1700 - 1707
• Main Authors: Wang, Chan-Ung, Arai, Yoshie, Kim, Insun, Jang, Wonhee, Lee, Seonghyun, Hafner, Jason H., Jeoung, Eunhee, Jung, Deokho, Kwon, Youngeun
• Format: Journal Article
• Language: English
• Published: Seoul The Korean Physical Society 01.05.2012; 한국물리학회
• Subjects: Mathematical and Computational Physics; Particle and Nuclear Physics; Physics; Physics and Astronomy; Theoretical; 물리학; Cytotoxicity; Gold nanorod; PEGylation; Antibody-conjugation
• ISSN: 0374-4884; 1976-8524
• DOI: 10.3938/jkps.60.1700

Abstact Gold nanoparticles (GNPs) have unique properties that make them highly attractive materials for developing functional reagents for various biomedical applications including photothermal therapy, targeted drug delivery, and molecular imaging. For in vivo applications, GNPs need to be prepared with very little or negligible cytotoxicitiy. Most GNPs are, however, prepared using growth-directing surfactants such as cetyl trimethylammonium bromide (CTAB), which are known to have considerable cytotoxicity. In this paper, we describe an approach to remove CTAB to a non-toxic concentration. We optimized the conditions for surface modification with methoxypolyethylene glycol thiol (mPEG), which replaced CTAB and formed a protective layer on the surface of gold nanorods (GNRs). The cytotoxicities of pristine and surface-modified GNRs were measured in primary human umbilical vein endothelial cells and human cell lines derived from hepatic carcinoma cells, embryonic kidney cells, and thyroid papillary carcinoma cells. Cytotoxicity assays revealed that treating cells with GNRs did not significantly affect cell viability except for thyroid papillary carcinoma cells. Thyroid cancer cells were more susceptible to residual CTAB, so CTAB had to be further removed by dialysis in order to use GNRs for thyroid cell targeting. PEGylated GNRs are further modified to present monoclonal antibodies that recognize a specific surface marker, Na-I symporter, for thyroid cells. Antibody-conjugated GNRs specifically targeted human thyroid cells in vitro .